What type of company are you?

Clinic

Which procedures areas do you support?

Fertility treatments

Where do you undertake the procedures or treatment?

Argentina

Which languages do you support?

English, Spanish

What accreditations do you or your affiliated medical facilities have?

None

What services do you provide?

Egg Donation

The use of donor oocytes in assisted reproduction techniques (ART) is becoming increasingly popular. Infertile patients with poor ovarian reserve, history of poor ovarian response to stimulation, those with multiple IVF failures or advanced maternal age, are among the patients commonly treated with donor oocytes, in order to improve their chances of becoming pregnant.

In 1993, CEGYR started running an Egg Donor Program. The aim of this program is to allow getting pregnant to hundreds of women that every year would like to make true this dream but cannot use their own oocytes. Egg donation is an alternative that offers best pregnancy rates with low genetic disorders chances (lower miscarriage rate and lower chromosomal abnormalities than pregnancies with own eggs coming from older women).

The advantages of doing it in CEGYR, Argentina

Most programs in United States use one oocyte donor for one recipient. Our program shares the donor egg cohort among multiple recipients (split cycles), allowing for a good pregnancy rate (50%) with a reduction of their waiting period and reducing costs since donor costs are shared by the various recipients, making this therapy affordable for most patients. Besides, as Argentine currency was devaluated in December 2001, costs for foreign patients are still lower.

Egg donor program of CEGYR is one of the most popular, not only in Argentina, but also in Latin America. Every year more than 250 women receive donated oocytes, and about 20% of them are people coming from abroad (mainly from USA, and also from Uruguay, Chile, Sweden, Netherlands, Spain, Mexico, Brazil and Peru).

Professionals working in CEGYR make it not only a high level medicine institution, but also guarantee patients a charm treat and a safe program as those running in USA. CEGYR has an ISO 9001 certification of quality, and follows the keys principles of the ACT (assisted conception taskforce).

Dr. Demián Glujovsky coordinates the Egg Donor Program of CEGYR. His background in Gynecology and Obstetrics with a specialization in Reproductive Medicine, and his studies in epidemiology, biostatistics and public health (Master of Clinical and Health Care Effectiveness) allowed him to run this program at CEGYR, an internationally-recognized high level fertility center that was founded in 1983.

Egg donor screening

All our voluntary egg donors are between 21 and 34 years old and they are screened following the American Society of Reproductive Medicine (ASRM) guidelines. Their medical personal and familial history is assessed by a genetist. They have an infectious (HIV, hepatitis B and C and syphilis) and genetic (karyotype and cystic fibrosis) screening. They also are evaluated by a psychologist and a psychological test (MMPI-2) is done.

Egg recipient

It is also important to do a complete evaluation of the recipient couple in order to minimize risks and optimize chances of getting pregnant. Age limit: women up to 50 years old. Screening checklist is the following (based in ASRM guidelines):

Patient:

• Type & Rh Factor
• HIV 1 - 2
• HBsAg
• HCV core antibody
• RPR (syphilis)
• Rubella IgG
• PAP smear
• Baseline Ultrasound
• Hysterosalpingography or Hysteroscopy
• GC and Chlamydia culture

Patients over 40 years old:

• CBC
• Hepatogram
• LDL cholesterol - HDL cholesterol - triglicerids
• Glycemia (fasting)
• EKG
• Mammography

Partner:

• Type & Rh Factor
• HIV 1 - 2
• HBsAg
• HCV core antibody
• RPR (syphilis)
• Semen analysis (with Kruger morphology)

Average time for a recipient is 2-3 months. Every couple can choose between two different plans in order to receive four or eight mature eggs. This means that no risks about an hypothetical poor donor ovarian response exist for the recipient.

Clinical outcomes (results)

Our clinical pregnancy rate is 45-50%, which is similar to most in USA and is higher than those published by the European Society of Human Reproductive and Endocrinology (ESHRE) and Latin-American registry (Registro Latinoamericano de Reproducción Asistida). It is important to emphasize that, unlike treatments using non-donor eggs, in oocyte donation, recipient age that not affects success rates, and clinical pregnancy rate is steady in women below 50 years old. It is also remarkable that egg donation is a therapeutic alternative effective and safe when it is done in a protocolized practice, following international statements based on clinical evidence.